TNFSF4 and asthma: TSLP activates human myeloid DCs to induce OX40L which triggers an inflammatory Th2 response characterized by high levels of TNF-α and low levels of IL-10 production, representing pathogenic Th2 cells involved in allergic inflammatory diseases such as asthma (36–38).